ArticleCancer management and research2021

The Efficacy and Toxicity of Neoadjuvant Chemotherapy Regimens of Epirubicin Plus Cyclophosphamide Followed by Docetaxel or Paclitaxel in Female Breast Cancer Patients.

Xian Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.